Professional Documents
Culture Documents
The Purchase order to PT. Tempo For Product Actemra 400 mg. 2 vial ( as per purchase order number
PO210800014 as : per-attached) is intended for treatment of hospitalized patient with severe COVID-19 patients.
Hospital RSUD Waluyo Jati Kraksaan is fully aware that the usage of drugs as mentioned above is for an
unlicensed indication Indonesia.
(In Indonesia. Actemra (Tocilizumab) is approve by BPOM for Rheumatoid Arthritis (RA), Polyarticular
Juvenile Indiopathict Arthritis (pJIA), and Systemic Juvenile idiopathic Arthritis (sJIA). It is not approved for the
treatment of fiospiialized COVID-19 patients. As evaluating the risk-benefit profile of Actemra use is important
for Patient Safety Risk management, Roch encourage HCP to report the use of Actemra in COVID-19 patients
and is adverse event through online form: https://cf>rt roche.com/a contact Roche
Patient Safety atindonesi&safetyr@rovhe.com].
Jl. Dr. Soetomo No.1
[‘ SURAT PESANAN
Telp.(0335) 841118,841481,Fax (0335) 841160